支持中國科學家 、公共衛生從業者及醫務人員抗擊COVID-19的聲明 - 生物行業前沿動態Forward trend - 細胞凍存液|胎牛血清|細胞株|細胞培養基|ELISA試劑盒|ECL發光液|國產血清|澳洲血清|完全培養基-上海尊龍凱時生物科技有限公司
申請試用裝
您當前的位置 :首頁 > 最新動態 > 前沿動態
支持中國科學家 、公共衛生從業者及醫務人員抗擊COVID-19的聲明


尊龍凱時是公共衛生領域的科學家 ,始終密切關注2019冠狀病毒病(COVID-19)的發生和發展 ,也對該疾病給全球人類健康福祉帶來的影響深感擔憂 。同時 ,尊龍凱時也看到特別是中國的科學家 、公共衛生從業者和醫務人員 ,務實 、高效 、迅速查明病原體 ,采取重大措施降低疫情影響 ,並與全球健康界分享成果 ,做到信息透明化 。他們不懈的努力值得稱讚。

 

通過簽署此聲明 ,尊龍凱時願和所有繼續在COVID-19暴發期間拯救生命 、守護全球衛生的中國科學家及健康工作者團結在一起 。疫情麵前 ,尊龍凱時同舟共濟 ,與奮戰在一線的中國同僚共同抗擊這種新型病毒的威脅 。

 

此次疫情期間 ,數據信息做到迅速 、公開 、透明化共享 ,但卻在當下遭受有關疾病起源的謠言和虛假信息的不良影響 。尊龍凱時在此一同強烈譴責“認為COVID-19並非自然起源”的陰謀論 。世界多國的科學家都分析了病原體“嚴重急性呼吸綜合征冠狀病毒2型(SARS-CoV-2)”的基因組 ,並公開發表了分析結果[1] ,壓倒性地得出一致結論 ,即此種冠狀病毒起源於野生動物[2-10] ,這和其他許多新發病原體一樣[11, 12] 。這項結論更是進一步得到了美國國家科學院 、工程院 、醫學院的院長們[13]及其所代表的科學界人士的來信支持 。陰謀論除了在抗擊疫情期間製造威脅全球團結力量的恐慌 、謠言 、偏見外 ,一無是處 。尊龍凱時支持世界衛生組織(WHO)總幹事的呼籲 ,要推進科學論證和團結 ,拒絕謠言與揣測 [14] 。尊龍凱時希望所有的讀者以及中國所有科研和醫務人員知道 :在這場病毒阻擊戰中 ,尊龍凱時與你們同在 。


尊龍凱時邀請更多人加入 ,一同支持武漢和中國各地的科學家 、公共衛生從業者及醫務人員。讓尊龍凱時共同在抗疫一線攜手前行 !END

作者介紹及聲明


LM is editor of ProMED-mail. We declare no competing interests.


Colorado State University, Fort Collins, CO, USA (CC); Scowcroft Institute of International Affairs, Texas A&M, College Station, TX, USA (DC); University of Maryland, College Park, MD, USA (RC); NEIDL Institute (RBC), Boston University (GTK), Boston, MA, USA; EcoHealth Alliance, New York, NY, USA (PD); Charité – Universitatsmedizin Berlin, Berlin, Germany (CD); National Center of Biotechnology, Madrid, Spain (LE); The Wellcome Trust, London, UK (JF, JG, MT); School of Veterinary Science, The University of Queensland, Brisbane, QLD, Australia (HF); Leiden University Medical Center, Leiden, Netherlands (AG); Erasmus Medical Center, Rotterdam, Netherlands (BH); Emory University, Atlanta, GA, USA (JMH); World Organization for Animal Health (OIE) Working Group on Wildlife, New York, NY, USA (WBK); University of Malaya, Kuala Lumpur, Malaysia (SKL); Food and Agriculture Organization of the United Nations, Rome, Italy (JL); Curtin University, Perth, WA, Australia (JSM); Massachusetts Medical School, Worcester, MA, USA (LM); University of California at Davis, Davis, CA, USA (JM); Department of Microbiology, Icahn School of Medicine, Mt Sinai Hospital, New York, NY, USA (PP); University of Iowa, Roy J and Lucille A Carver College of Medicine, Iowa City, IA, USA (SP); The University of Hong Kong, Hong Kong (LP); University of Chicago, Chigaco, IL, USA (BR); The Ohio State University, Columbus, OH, USA (LS); and The University of Melbourne, Melboune, VIC, Australia (KS)




參考文獻(上下滑動查看)


[1] Gorbalenya AE, Baker SC, Baric RS, et al. Severe acute respiratory syndrome-related coronavirus: the species and its viruses—a statement of the Coronavirus Study Group. bioRxiv 2020; published online Feb 11. DOI:2020.02.07.937862 (preprint).

[2] Zhou P, Yang X-L, Wang X-G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; published online Feb 3. DOI:10.1038/s41586-020-2012-7.

[3] Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020; published online Jan 30. https://doi.org/10.1016/S0140-6736(20)30251-8.

[4] Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. NEJM 2020; published online Jan 24. DOI:10.1056/NEJMoa2001017.

[5] Ren L, Wang Y-M, Wu Z-Q, et al. Identification of a novel coronavirus causing severe pneumonia in humans: a descriptive study. Chin Med J 2020; published online Feb 11. DOI:10.1097/CM9.0000000000000722.

[6] Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Tsiodras S. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol 2020; published online Jan 29. DOI:10.1016/j.meegid.2020.104212.

[7] Benvenuto D, Giovanetti M, Ciccozzi A, Spoto S, Angeletti S, Ciccozzi M. The 2019-new coronavirus epidemic: evidence for virus evolution. J Med Virol 2020; published online Jan 29. DOI:10.1002/jmv.25688.

[8] Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by novel coronavirus from Wuhan: an analysis based on decadelong structural studies of SARS. J Virol 2020; published online Jan 29. DOI:10.1128/JVI.00127-20.

[9] US Center for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19) situation summary. Feb 16, 2020. https://www.cdc.gov/coronavirus/2019-nCoV/summary.html (accessed Feb 8, 2020).

[10] Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Feb 16, 2020;  https://virological.org/t/the-proximal-origin-of-sars-cov-2/398(accessed Feb 17, 2020).

[11] Bengis R, Leighton F, Fischer J, Artois M, Morner T, Tate C. The role of wildlife in emerging and re-emerging zoonoses. Rev Sci Tech 2004; 23: 497–512.

[12] Woolhouse ME, Gowtage-Sequeria S. Host range and emerging and reemerging pathogens. Emerg Infect Dis 2005; 11: 1842–47.

[13] NASEM. The National Academies of Science Engineering and Medicine of the USA. NAS, NAE, and NAM presidents’ letter to the White House Office of Science and Technology Policy. Feb 6, 2020. https://www.nationalacademies.org/includes/NASEM%20Response%20to%20OSTP%20re%20Coronavirus_February%206,%202020.pdf (accessed Feb 7, 2020).

[14] WHO. Director-General’s remarks at the media briefing on 2019 novel coronavirus on 8 February 2020. Feb 8, 2020. https://www.who.int/dg/speeches/detail/director-generals-remarks-at-the-media-briefing-on-2019-novel-coronavirus---8-february-2020 (accessed Feb 18, 2020).


公司簡介 / Company profile
上海尊龍凱時生物科技有限公司
Shanghai Chuan Qiu Biotechnology Co.,Ltd.
       公司主要依托複旦大學 、同濟大學等上海地區多家著名高校 ,擁有一支富有經驗的開發團隊 ,專業從事細胞及細胞...
聯係尊龍凱時 / Contact
電 話 :021-69950217  173-2144-0983
傳 真 :021-69950218
郵 箱 :2078251929@qq.com
郵 編 :201800
地 址 :上海市嘉定區翔江公路518號寅尚產業園D座210室
Copyright © 2018 CHUANQIU Biotechnology Co.,Ltd. All Rights Reserved. 滬ICP備18030131號-1
  • 申請試用裝
  • 021-69950217